Q3 2024 Holdings
Filed 2024-11-13 | 6 holdings | $145.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $70.7M | 4,425,784 | 48.7% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $28.0M | 2,738,785 | 19.2% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $24.5M | 682,376 | 16.9% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $9.1M | 4,284,172 | 6.3% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $7.7M | 2,242,636 | 5.3% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $5.3M | 5,555,461 | 3.6% |